Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

Secondary IO refractory cancers

Strategies to overcome PD1 resistance in melanoma

Date

12 Dec 2024

Session

Secondary IO refractory cancers

Topics

Therapy

Tumour Site

Central Nervous System Malignancies;  Skin Cancers

Presenters

Anna Di Giacomo

Authors

A.M. Di Giacomo

Author affiliations

  • University of Siena, Siena/IT

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.